Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancies

被引:0
|
作者
Rejeski, K. [1 ,2 ,3 ]
Tebaldi, T. [1 ]
Joshi, P. [1 ]
Liang, Y. [1 ]
Pfeifer, D. [2 ]
Luebbert, M. [2 ]
Halene, S. [1 ]
机构
[1] Yale Univ, Sch Med, Sect Hematol, Yale Canc Ctr, New Haven, CT USA
[2] Univ Klinikum Freiburg, Med Klin 1, Onkol & Stammzelltransplantat, Freiburg, Germany
[3] LMU Grosshadern, Med Klin 3, Hamatol & Onkol, Munich, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V540
引用
收藏
页码:144 / 144
页数:1
相关论文
共 50 条
  • [31] SRSF2 safeguards efficient transcription of DNA damage and repair genes
    Wagner, Rebecca E.
    Arnetzl, Leonie
    Britto-Borges, Thiago
    Heit-Mondrzyk, Anke
    Bakr, Ali
    Sollier, Etienne
    Gkatza, Nikoletta A.
    Panten, Jasper
    Delaunay, Sylvain
    Sohn, Daniela
    Schmezer, Peter
    Odom, Duncan T.
    Mueuroller-Decker, Karin
    Plass, Christoph
    Dieterich, Christoph
    Cancer, German
    Lutsik, Pavlo
    Bornelov, Susanne
    Frye, Michaela
    CELL REPORTS, 2024, 43 (11):
  • [32] Myeloid Malignancies With Isochromosome 17q Harbor Frequently Mutations In ASXL1, SETBP1, and SRSF2 - This Distinct Genotype Presents With Various Morphological Phenotypes
    Meggendorfer, Mania
    Alpermann, Tamara
    Haferlach, Claudia
    Sirch, Elisabeth
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    BLOOD, 2013, 122 (21)
  • [33] SRSF2 in Sertoli cells is essential for testicular development and spermatogenesis in mice
    Xie, Xiaomei
    Sun, Longjie
    Duan, Yixi
    Lv, Zheng
    Yao, Xiaohong
    Wang, Chaofan
    Chen, Xuexue
    Tian, Shuang
    Yan, Lu
    Shao, Yujing
    Luo, Haoshu
    Liu, Jiali
    FASEB JOURNAL, 2023, 37 (05):
  • [34] Recurrent SRSF2 mutations in MDS affect both splicing and NMD
    Rahman, Mohammad Alinoor
    Lin, Kuan-Ting
    Bradley, Robert K.
    Abdel-Wahab, Omar
    Krainer, Adrian R.
    GENES & DEVELOPMENT, 2020, 34 (5-6) : 413 - 427
  • [35] Serine Rich Splicing Factor 2 (SRSF2) Flips for RNA Binding
    Arnholt, Mark
    Bohn, M.
    Cina, M.
    Downing, A.
    Flanagan, M.
    Hautala, L.
    Jaeke, A.
    Kennedy, C.
    Lane, B.
    O'Bryon, A.
    Pepin, J.
    Rohloff, E.
    Rrahmani, F.
    Schmitt, S.
    Spudich, J.
    Staus, S.
    Tadlock, K.
    Tomashek, M.
    Witt, E.
    McNally, Mark
    FASEB JOURNAL, 2018, 32 (01):
  • [36] Canonical and Non-Canonical SRSF2 Variants Correlate with Different Bone Marrow Morphologic and Clinical Outcomes in Myeloid Disease
    Wilton, Katelynn
    Jambhekar, Ashwini
    Nandagopal, Nagarajan
    Fell, Geoffrey
    Lovitch, Scott
    Kim, Annette
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1501 - S1502
  • [37] The structure and selectivity of the SR protein SRSF2 RRM domain with RNA
    Phelan, Marie M.
    Goult, Benjamin T.
    Clayton, Jonathan C.
    Hautbergue, Guillaume M.
    Wilson, Stuart A.
    Lian, Lu-Yun
    NUCLEIC ACIDS RESEARCH, 2012, 40 (07) : 3232 - 3244
  • [38] SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development
    Luo, Chunling
    Cheng, Yuanming
    Liu, Yuguo
    Chen, Linlin
    Liu, Lina
    Wei, Ning
    Xie, Zhiqin
    Wu, Wenwu
    Feng, Ying
    CANCER RESEARCH, 2017, 77 (05) : 1168 - 1178
  • [39] SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
    Meggendorfer, Manja
    Roller, Andreas
    Haferlach, Torsten
    Eder, Christiane
    Dicker, Frank
    Grossmann, Vera
    Kohlmann, Alexander
    Alpermann, Tamara
    Yoshida, Kenichi
    Ogawa, Seishi
    Koeffler, H. Phillip
    Kern, Wolfgang
    Haferlach, Claudia
    Schnittger, Susanne
    BLOOD, 2012, 120 (15) : 3080 - 3088
  • [40] CLINICAL STUDY OF SRSF2 MUTATION IN CHINESE WITH CHRONIC MYELOMONOCYTIC LEUKEMIA
    Sun, C.
    Zhang, S.
    Yang, X.
    Li, J.
    HAEMATOLOGICA, 2014, 99 : 674 - 674